Picture of Thermogenesis Holdings logo

THMO — Thermogenesis Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyHighly SpeculativeMicro Cap

Brief: Cesca Therapeutics Announces Q2 Loss Per Share $0.47

Aug 13 (Reuters) - Cesca Therapeutics Inc  KOOL.O :
    * CESCA THERAPEUTICS ANNOUNCES IMPROVED SECOND QUARTER 2019
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
    * Q2 LOSS PER SHARE $0.47
    * Q2 REVENUE ROSE 115 PERCENT TO $4.3 MILLION
    * AT JUNE 30, 2019, COMPANY HAD CASH AND CASH EQUIVALENTS
TOTALLING APPROXIMATELY $2.4 MILLION

Source text for Eikon:  ID:nPnbPwZnva 
Further company coverage:  KOOL.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Thermogenesis Holdings

See all news